Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United KingdomProduct Supply Agreement • December 9th, 2021
Contract Type FiledDecember 9th, 2021BURLINGTON, Ontario – December 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland Health Limited (“Oakland Health” operating as “RD Therapeutics”) to supply QuickStrip™ products to the United Kingdom and the European Union.
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United KingdomProduct Supply Agreement • December 8th, 2021
Contract Type FiledDecember 8th, 2021BURLINGTON, Ontario – December 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has entered into an agreement with Oakland Health Limited (“Oakland Health” operating as “RD Therapeutics”) to supply QuickStrip™ products to the United Kingdom and the European Union.